{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T07:08:32Z","timestamp":1782371312492,"version":"3.54.5"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Urol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11934-025-01307-y","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T01:23:25Z","timestamp":1764293005000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Testosterone and Lower Urinary Tract Symptoms: A Narrative Review"],"prefix":"10.1007","volume":"26","author":[{"given":"Colin J.","family":"O\u2019Mahony","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A.","family":"Arshad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. M.","family":"Norton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"issue":"2","key":"1307_CR1","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/nau.10052","volume":"21","author":"P Abrams","year":"2002","unstructured":"Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn. 2002;21(2):167\u201378. https:\/\/doi.org\/10.1002\/nau.10052.","journal-title":"Neurourol Urodyn"},{"issue":"Suppl 3","key":"1307_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1464-410X.2009.08371.x","volume":"103","author":"KS Coyne","year":"2009","unstructured":"Coyne KS, Wein AJ, Tubaro A, Sexton CC, Thompson CL, Kopp ZS, et al. The burden of lower urinary tract symptoms: evaluating the effect of LUTS on health-related quality of life, anxiety and depression: EpiLUTS. BJU Int. 2009;103(Suppl 3):4\u201311. https:\/\/doi.org\/10.1111\/j.1464-410X.2009.08371.x.","journal-title":"BJU Int"},{"issue":"2","key":"1307_CR3","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s00345-010-0605-8","volume":"29","author":"SA Martin","year":"2011","unstructured":"Martin SA, Haren MT, Marshall VR, Lange K, Wittert GA. Prevalence and factors associated with uncomplicated storage and voiding lower urinary tract symptoms in community-dwelling Australian men. World J Urol. 2011;29(2):179\u201384. https:\/\/doi.org\/10.1007\/s00345-010-0605-8.","journal-title":"World J Urol"},{"issue":"5","key":"1307_CR4","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.eururo.2016.07.007","volume":"70","author":"M Gacci","year":"2016","unstructured":"Gacci M, Corona G, Sebastianelli A, Serni S, De Nunzio C, Maggi M, et al. Male lower urinary tract symptoms and cardiovascular events: a systematic review and meta-analysis. Eur Urol. 2016;70(5):788\u201396. https:\/\/doi.org\/10.1016\/j.eururo.2016.07.007.","journal-title":"Eur Urol"},{"issue":"7","key":"1307_CR5","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1007\/s40618-021-01775-1","volume":"45","author":"G Rastrelli","year":"2022","unstructured":"Rastrelli G, Cipriani S, Lotti F, Cellai I, Comeglio P, Filippi S, et al. Testosterone does not affect lower urinary tract symptoms while improving markers of prostatitis in men with benign prostatic hyperplasia: a randomized clinical trial. J Endocrinol Invest. 2022;45(7):1413\u201325. https:\/\/doi.org\/10.1007\/s40618-021-01775-1.","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"1307_CR6","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nrurol.2015.304","volume":"13","author":"L Vignozzi","year":"2016","unstructured":"Vignozzi L, Gacci M, Maggi M. Lower urinary tract symptoms, benign prostatic hyperplasia and metabolic syndrome: a nexus. Nat Rev Urol. 2016;13(2):108\u201319. https:\/\/doi.org\/10.1038\/nrurol.2015.304.","journal-title":"Nat Rev Urol"},{"key":"1307_CR7","doi-asserted-by":"publisher","first-page":"175628722110039","DOI":"10.1177\/17562872211003947","volume":"13","author":"A Omran","year":"2021","unstructured":"Omran A, Ghoniem G, Taha DE, et al. Metabolic syndrome is associated with prostate enlargement: a meta-analysis. Ther Adv Urol. 2021;13:17562872211003947. https:\/\/doi.org\/10.1177\/17562872211003947.","journal-title":"Ther Adv Urol"},{"key":"1307_CR8","doi-asserted-by":"publisher","first-page":"121662","DOI":"10.1016\/j.lfs.2024.121662","volume":"347","author":"X Fu","year":"2024","unstructured":"Fu X, Hu H, Wang Y, et al. Association between metabolic syndrome and benign prostatic hyperplasia: updated evidence. Life Sci. 2024;347:121662. https:\/\/doi.org\/10.1016\/j.lfs.2024.121662.","journal-title":"Life Sci"},{"issue":"Suppl 3","key":"1307_CR9","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/bju.12728","volume":"115","author":"M Gacci","year":"2015","unstructured":"Gacci M, Corona G, Vignozzi L, et al. Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis. BJU Int. 2015;115(Suppl 3):24\u201331. https:\/\/doi.org\/10.1111\/bju.12728.","journal-title":"BJU Int"},{"issue":"13","key":"1307_CR10","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1002\/pros.22686","volume":"73","author":"L Vignozzi","year":"2013","unstructured":"Vignozzi L, Gacci M, Cellai I, et al. PDE5 inhibitors blunt inflammation in human BPH: a potential mechanism of action for PDE5 inhibitors in LUTS. Prostate. 2013;73(13):1391\u2013402. https:\/\/doi.org\/10.1002\/pros.22686.","journal-title":"Prostate"},{"issue":"4","key":"1307_CR11","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/pros.22623","volume":"73","author":"L Vignozzi","year":"2013","unstructured":"Vignozzi L, Gacci M, Cellai I, et al. Fat boosts, while androgen receptor activation counteracts, BPH-associated prostate inflammation. Prostate. 2013;73(4):409\u201317. https:\/\/doi.org\/10.1002\/pros.22623.","journal-title":"Prostate"},{"issue":"1","key":"1307_CR12","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1530\/JOE-11-0289","volume":"212","author":"L Vignozzi","year":"2012","unstructured":"Vignozzi L, Morelli A, Sarchielli E, et al. Testosterone protects from metabolic syndrome-associated prostate inflammation: an experimental study in rabbit. J Endocrinol. 2012;212(1):71\u201384. https:\/\/doi.org\/10.1530\/JOE-11-0289.","journal-title":"J Endocrinol"},{"issue":"1","key":"1307_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.eururo.2025.01.010","volume":"88","author":"European Association of Urology","year":"2025","unstructured":"European Association of Urology. Management of non-neurogenic male LUTS: EAU guidelines 2025. Eur Urol. 2025;88(1):1\u201345. https:\/\/doi.org\/10.1016\/j.eururo.2025.01.010.","journal-title":"Eur Urol"},{"issue":"1","key":"1307_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/JU.0000000000003109","volume":"210","author":"American Urological Association","year":"2023","unstructured":"American Urological Association. Management of LUTS attributed to BPH: 2023 guideline. J Urol. 2023;210(1):1\u201318. https:\/\/doi.org\/10.1097\/JU.0000000000003109.","journal-title":"J Urol"},{"issue":"11","key":"1307_CR15","doi-asserted-by":"publisher","first-page":"e2332912","DOI":"10.1001\/jamanetworkopen.2023.32912","volume":"6","author":"S Bhasin","year":"2023","unstructured":"Bhasin S, Travison TG, Pencina KM, et al. Prostate safety events during testosterone replacement therapy in men with hypogonadism: TRAVERSE trial. JAMA Netw Open. 2023;6(11):e2332912. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.32912.","journal-title":"JAMA Netw Open"},{"key":"1307_CR16","doi-asserted-by":"publisher","first-page":"1335146","DOI":"10.3389\/fendo.2024.1335146","volume":"15","author":"Z Xu","year":"2024","unstructured":"Xu Z, Chen X, Zhou J, et al. Testosterone therapy in hypogonadal men: updated systematic review and meta-analysis. Front Endocrinol (Lausanne). 2024;15:1335146. https:\/\/doi.org\/10.3389\/fendo.2024.1335146.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1307_CR17","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.urology.2024.02.009","volume":"186","author":"X Yuan","year":"2024","unstructured":"Yuan X, Zhang X, Chen G, et al. Effect of testosterone replacement therapy on lower urinary tract symptoms: a systematic review and network meta-analysis. Urology. 2024;186:66\u201374. https:\/\/doi.org\/10.1016\/j.urology.2024.02.009.","journal-title":"Urology"},{"issue":"7","key":"1307_CR18","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1007\/s40618-021-01775-1","volume":"45","author":"G Rastrelli","year":"2022","unstructured":"Rastrelli G, Vignozzi L, Sforza A, et al. Testosterone therapy and prostatic inflammation markers in hypogonadal men with lower urinary tract symptoms: randomized data. J Endocrinol Invest. 2022;45(7):1413\u201325. https:\/\/doi.org\/10.1007\/s40618-021-01775-1.","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"1307_CR19","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1002\/nau.24596","volume":"40","author":"C Lin","year":"2021","unstructured":"Lin C, Chen J, Li H, et al. Androgen deprivation alters detrusor function in experimental models: implications for lower urinary tract symptoms. Neurourol Urodyn. 2021;40(2):529\u201338. https:\/\/doi.org\/10.1002\/nau.24596.","journal-title":"Neurourol Urodyn"},{"issue":"6","key":"1307_CR20","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.5664\/jcsm.9932","volume":"18","author":"Y Chen","year":"2022","unstructured":"Chen Y, Yang S, Hu S, et al. Obstructive sleep Apnoea treatment and testosterone: effects on nocturia and endocrine function. J Clin Sleep Med. 2022;18(6):1593\u2013601. https:\/\/doi.org\/10.5664\/jcsm.9932.","journal-title":"J Clin Sleep Med"},{"key":"1307_CR21","doi-asserted-by":"publisher","first-page":"741748","DOI":"10.3389\/fendo.2022.741748","volume":"13","author":"C Xin","year":"2022","unstructured":"Xin C, Li Y, Yan J, et al. Impact of diabetes mellitus on LUTS in benign prostatic hyperplasia: systematic review and meta-analysis. Front Endocrinol (Lausanne). 2022;13:741748. https:\/\/doi.org\/10.3389\/fendo.2022.741748.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"1307_CR22","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1002\/nau.24376","volume":"39","author":"K Kadekawa","year":"2020","unstructured":"Kadekawa K, Tyagi P, Saito M, et al. Androgen receptor distribution in the pelvic floor and lower urinary tract: implications for function. Neurourol Urodyn. 2020;39(5):1280\u201391. https:\/\/doi.org\/10.1002\/nau.24376.","journal-title":"Neurourol Urodyn"},{"issue":"4","key":"1307_CR23","doi-asserted-by":"publisher","first-page":"746","DOI":"10.3390\/cancers16040746","volume":"16","author":"D Sundi","year":"2024","unstructured":"Sundi D, Mostafid AH, Sfakianos JP, et al. Roles of androgen receptor signalling in urothelial biology and disease. Cancers (Basel). 2024;16(4):746. https:\/\/doi.org\/10.3390\/cancers16040746.","journal-title":"Cancers (Basel)"},{"issue":"3","key":"1307_CR24","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1080\/13685530802249116","volume":"11","author":"S Karazindiyano\u011flu","year":"2008","unstructured":"Karazindiyano\u011flu S, Cayan S. The effect of testosterone therapy on lower urinary tract symptoms\/bladder and sexual functions in men with symptomatic late-onset hypogonadism. Aging Male. 2008;11(3):146\u20139. https:\/\/doi.org\/10.1080\/13685530802249116.","journal-title":"Aging Male"},{"issue":"4 Pt 1","key":"1307_CR25","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.juro.2015.10.091","volume":"195","author":"R Tkacova","year":"2016","unstructured":"Tkacova R, Javorkova M, McNicholas WT, et al. Continuous positive airway pressure improves nocturnal polyuria and nocturia in obstructive sleep Apnoea. J Urol. 2016;195(4 Pt 1):1123\u201330. https:\/\/doi.org\/10.1016\/j.juro.2015.10.091.","journal-title":"J Urol"},{"issue":"3","key":"1307_CR26","first-page":"191","volume":"3","author":"O Arjamaa","year":"2011","unstructured":"Arjamaa O, Nikinmaa M. Hypoxia regulates the natriuretic peptide system. Int J Physiol Pathophysiol Pharmacol. 2011;3(3):191\u2013201. PMID:21941610.","journal-title":"Int J Physiol Pathophysiol Pharmacol"},{"issue":"3","key":"1307_CR27","doi-asserted-by":"publisher","first-page":"178","DOI":"10.5213\/inj.2015.19.3.178","volume":"19","author":"T Wang","year":"2015","unstructured":"Wang T, Huang W, Zong H, Zhang Y. The efficacy of continuous positive airway pressure therapy on nocturia in patients with obstructive sleep apnea: a systematic review and meta-analysis. Int Neurourol J. 2015;19(3):178\u201384. https:\/\/doi.org\/10.5213\/inj.2015.19.3.178.","journal-title":"Int Neurourol J"},{"key":"1307_CR28","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.urology.2016.06.022","volume":"97","author":"SA Martin","year":"2016","unstructured":"Martin SA, Appleton SL, Adams RJ, et al. Nocturia, other lower urinary tract symptoms and sleep dysfunction in a community-dwelling cohort of men. Urology. 2016;97:219\u201326. https:\/\/doi.org\/10.1016\/j.urology.2016.06.022.","journal-title":"Urology"},{"issue":"1","key":"1307_CR29","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.euf.2024.12.005","volume":"11","author":"D Koh","year":"2025","unstructured":"Koh D, Brookes M, Rohde V, et al. Multisystem mechanisms linking hypogonadism, inflammation, and bladder dysfunction in men. Eur Urol Focus. 2025;11(1):45\u201355. https:\/\/doi.org\/10.1016\/j.euf.2024.12.005.","journal-title":"Eur Urol Focus"},{"key":"1307_CR30","doi-asserted-by":"publisher","first-page":"1362108","DOI":"10.3389\/fendo.2024.1362108","volume":"15","author":"G Rastrelli","year":"2024","unstructured":"Rastrelli G, Corona G, Vignozzi L. Metabolic drugs in men\u2019s health: GLP-1 receptor agonists and androgens in synergy. Front Endocrinol (Lausanne). 2024;15:1362108. https:\/\/doi.org\/10.3389\/fendo.2024.1362108.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"1307_CR31","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/j.jsxm.2018.07.013","volume":"15","author":"L Vignozzi","year":"2018","unstructured":"Vignozzi L, Rastrelli G, Corona G, et al. Estradiol levels are positively associated with prostate inflammation and severity of lower urinary tract symptoms in men with benign prostatic hyperplasia. J Sex Med. 2018;15(9):1321\u201332. https:\/\/doi.org\/10.1016\/j.jsxm.2018.07.013.","journal-title":"J Sex Med"},{"key":"1307_CR32","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.urology.2020.08.046","volume":"147","author":"M Maggio","year":"2021","unstructured":"Maggio M, Lauretani F, Ceda GP, et al. Relationship between sex hormones and lower urinary tract symptoms in older men. Urology. 2021;147:178\u201385. https:\/\/doi.org\/10.1016\/j.urology.2020.08.046.","journal-title":"Urology"},{"issue":"5","key":"1307_CR33","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1111\/andr.13326","volume":"11","author":"C Zhao","year":"2023","unstructured":"Zhao C, Gao Y, Zhang J, et al. Correlation between sex hormone levels and prostate stiffness assessed by shear wave elastography in men with benign prostatic hyperplasia. Andrology. 2023;11(5):837\u201345. https:\/\/doi.org\/10.1111\/andr.13326.","journal-title":"Andrology"},{"issue":"3","key":"1307_CR34","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s41585-022-00700-1","volume":"20","author":"G Rastrelli","year":"2023","unstructured":"Rastrelli G, Corona G, Vignozzi L, et al. Aromatase inhibitors and selective oestrogen receptor modulators in men: physiological and clinical perspectives. Nat Rev Urol. 2023;20(3):173\u201388. https:\/\/doi.org\/10.1038\/s41585-022-00700-1.","journal-title":"Nat Rev Urol"},{"issue":"5","key":"1307_CR35","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1111\/cen.14685","volume":"96","author":"JW Kim","year":"2022","unstructured":"Kim JW, Park SY, Kim YJ, et al. Effects of aromatase Inhibition on lower urinary tract symptoms and metabolic parameters in obese hypogonadal men: a randomized controlled trial. Clin Endocrinol (Oxf). 2022;96(5):709\u201318. https:\/\/doi.org\/10.1111\/cen.14685.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"1307_CR36","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/iju.15124","volume":"31","author":"K Shigehara","year":"2024","unstructured":"Shigehara K, Namiki M, Izumi K. Selective estrogen receptor modulators in the treatment of male hypogonadism: clinical implications for metabolic and urological health. Int J Urol. 2024;31(2):178\u201386. https:\/\/doi.org\/10.1111\/iju.15124.","journal-title":"Int J Urol"},{"key":"1307_CR37","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.urology.2022.03.018","volume":"168","author":"A Morales","year":"2022","unstructured":"Morales A, Traish AM. Testosterone deficiency and muscle function: implications for pelvic floor and urinary control in ageing men. Urology. 2022;168:32\u20139. https:\/\/doi.org\/10.1016\/j.urology.2022.03.018.","journal-title":"Urology"},{"issue":"1","key":"1307_CR38","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1080\/13685538.2023.2174591","volume":"26","author":"KV Chang","year":"2023","unstructured":"Chang KV, Wu WT, Han DS, et al. Association between sarcopenia and lower urinary tract symptoms in older adults: a systematic review and meta-analysis. Aging Male. 2023;26(1):223\u201332. https:\/\/doi.org\/10.1080\/13685538.2023.2174591.","journal-title":"Aging Male"},{"issue":"2","key":"1307_CR39","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s40618-023-02074-2","volume":"47","author":"G Corona","year":"2024","unstructured":"Corona G, Vignozzi L, Rastrelli G, et al. Testosterone supplementation and muscle function: evidence-based insights for metabolic and urological health. J Endocrinol Invest. 2024;47(2):187\u201399. https:\/\/doi.org\/10.1007\/s40618-023-02074-2.","journal-title":"J Endocrinol Invest"},{"issue":"6","key":"1307_CR40","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.amjmed.2024.03.021","volume":"137","author":"V Jaiswal","year":"2024","unstructured":"Jaiswal V, Sarfraz Z, Kumar A, et al. Cardiovascular and mortality outcomes with testosterone therapy: a meta-analysis of randomized trials. Am J Med. 2024;137(6):650\u201361. https:\/\/doi.org\/10.1016\/j.amjmed.2024.03.021.","journal-title":"Am J Med"},{"issue":"2","key":"1307_CR41","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s11934-025-01234-9","volume":"26","author":"N Pereira","year":"2025","unstructured":"Pereira N, Ali H, Miceli T, et al. Integrating endocrine and urological management of testosterone deficiency and LUTS: evolving concepts. Curr Urol Rep. 2025;26(2):78\u201388. https:\/\/doi.org\/10.1007\/s11934-025-01234-9.","journal-title":"Curr Urol Rep"}],"container-title":["Current Urology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-025-01307-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11934-025-01307-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-025-01307-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T19:03:00Z","timestamp":1767985380000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11934-025-01307-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1307"],"URL":"https:\/\/doi.org\/10.1007\/s11934-025-01307-y","relation":{},"ISSN":["1527-2737","1534-6285"],"issn-type":[{"value":"1527-2737","type":"print"},{"value":"1534-6285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"assertion":[{"value":"20 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"75"}}